What is Leeisa?
Established in 1993, Leeisa operates as a specialized provider of laboratory equipment, high-grade chemicals, and essential support services. The firm serves as a vital bridge for US-based organizations looking to navigate the complexities of emerging world markets. By offering a comprehensive catalog that spans from heavy-duty laboratory instrumentation to specialized reagents, Leeisa ensures that research and industrial facilities are fully equipped to meet international standards. Their business model is built upon a foundation of deep domain expertise and a commitment to operational excellence, allowing them to mitigate the logistical challenges often associated with cross-border scientific procurement.
How much funding has Leeisa raised?
Leeisa has raised a total of $42K across 1 funding round:
Debt
$42K
Debt (2021): $42K with participation from PPP
Key Investors in Leeisa
PPP
Public-Private Partnership
What's next for Leeisa?
With the recent influx of capital, Leeisa is expected to accelerate its strategic initiatives aimed at scaling its distribution network and enhancing its service delivery capabilities. The company is likely to focus on deepening its footprint in high-growth regions where the demand for reliable laboratory infrastructure is outpacing local supply. By optimizing its supply chain and expanding its portfolio of technical support services, Leeisa aims to capture a larger share of the global research and development market. This phase of growth will be critical in transitioning the company from a niche supplier to a dominant force in international laboratory logistics, ensuring that they remain the preferred partner for organizations operating in complex, emerging economic environments.
See full Leeisa company page
